Contact
Please use this form to send email to PR contact of this press release:
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
TO:
Please use this form to send email to PR contact of this press release:
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
TO: